{
  "catalogId": "72ba6e6b-9310-4e25-ad70-2c63488b5b8d",
  "name": "ENTRESTO 100 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "154 98 34485 00",
  "treatmentDescriptions": "Entresto is indicated for the treatment of heart failure (NYHA class II-IV) in patients with systolic dysfunction. Entresto has been shown to reduce the rate of cardiovascular death and heart failure hospitalisation compared to angiotensin converting enzyme (ACE) inhibitor therapy.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "SACUBITRIL/VALSARTAN AS SODIUM SALT COMPLEX 49/51  MG",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "C09DX04",
      "name": "VALSARTAN AND SACUBITRIL"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "ENTRESTO 100 MG 56 F.C.TAB",
      "manufacturer": {
        "name": "נוברטיס פארמה",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 56.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PVDC/ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "7791",
        "yarpa": "32620",
        "pharmasoft": "5598",
        "barcode": "290014257498"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 413.9732907,
        "retailMargin": 17.5,
        "maxRetailPrice": 486.4186166,
        "maxPriceWithVAT": 573.9739676
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.593723"
  }
}